Baraclude (entecavir), a new oral antiviral for chronic hepatitis B
Some patients will be getting Baraclude (entecavir), a new oral antiviral for chronic hepatitis B.
It will be used as an alternative to Intron A (interferon alfa-2b)...Epivir-HBV (lamivudine)... or Hepsera (adefovir).
Intron A is effective for suppressing the hepatitis B virus and requires a shorter treatment duration than the oral antivirals.
Get concise advice on drug therapy, plus unlimited access to CE
Pharmacist's Letter membership benefits include:
- 12 issues every year — what you need to know and do, right now
- Quick, practical reference charts and tools
- Comprehensive CE library to meet license renewal and state requirements
- Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
- Plus much more!
Choose the right tier for your needs today.
Already a subscriber? Log in
Volume pricing available. Get a quote